Isabella Quinti: Difference between revisions
From Top Italian Scientists Wiki
No edit summary |
|||
| Line 32: | Line 32: | ||
==Work experience== | ==Work experience== | ||
* 1986-2002: Assistant Professor in Clinical Immunology, University of Rome “La Sapienza”, Italy | * 1986-2002: Assistant Professor in Clinical Immunology, University of Rome “La Sapienza”, Italy. | ||
* 2001-up to now: Head of the Primary Immunodeficiency Unit, Sapienza, University of Rome, Italy | * 2001-up to now: Head of the Primary Immunodeficiency Unit, Sapienza, University of Rome, Italy. | ||
* 2010-up to now: Professor PhD School, INNOVATION IN IMMUNO-MEDIATED AND HEMATOLOGICAL DISORDERS, Sapienza, University of Rome, Italy | * 2010-up to now: Professor PhD School, INNOVATION IN IMMUNO-MEDIATED AND HEMATOLOGICAL DISORDERS, Sapienza, University of Rome, Italy. | ||
* 2019-up to now: Director School of Specialty in Allergy and Clinical Immunology, Sapienza University of Rome, Sapienza, University of Rome, Italy | * 2019-up to now: Director School of Specialty in Allergy and Clinical Immunology, Sapienza University of Rome, Sapienza, University of Rome, Italy. | ||
* 2012-2020: Associate Professor in Internal Medicine, Clinical Immunology, Sapienza, University of Rome, Italy | * 2012-2020: Associate Professor in Internal Medicine, Clinical Immunology, Sapienza, University of Rome, Italy. | ||
* 2021-up to now: Full Professor in Internal Medicine, Clinical Immunology, Sapienza, University of Rome, Italy | * 2021-up to now: Full Professor in Internal Medicine, Clinical Immunology, Sapienza, University of Rome, Italy. | ||
== Education and training == | == Education and training == | ||
* 1972-1978: Medicine Degree, Sapienza University of Rome, Italy | * 1972-1978: Medicine Degree, Sapienza University of Rome, Italy. | ||
* 1978-1982: Specialist in Allergy and Clinical Immunology, Sapienza University of Rome, Italy | * 1978-1982: Specialist in Allergy and Clinical Immunology, Sapienza University of Rome, Italy. | ||
* 1983-1984: Research fellow in Paediatrics, Children Hospital, Harvard University, Boston, Ma, USA | * 1983-1984: Research fellow in Paediatrics, Children Hospital, Harvard University, Boston, Ma, USA. | ||
* 1983-1985: Ph.D. in Clinical Immunology, University of Bari, Italy | * 1983-1985: Ph.D. in Clinical Immunology, University of Bari, Italy. | ||
== Scientific skills and competences == | |||
* Primary Immunodeficiencies: natural history, clinical outcome, immune therapies. | |||
* Blymphocytes defects in primary immunodeficiencies syndromes. | |||
* Response to Immunizations. | |||
* B-cell lymphoproliferative disorders. | |||
* Mucosal immunity. | |||
== Relevant roles and competences == | |||
* 2001 up to now: Responsible for Italian Network on CVID (IPINET: Italian Primary Immunodeficiency Network). | |||
* 2008-2015: Responsible for the Sapienza Research Unit of the Medium-scale focused research Collaborative Research Project, founded by the European Commission:“Pathophysiology and Natural Course of Primary Antibody Deficiency (PAD) Syndromes (EURO-PADnet). 7° PQ EU. | |||
* 2010-2022: Responsible of the Jeffrey Modell Foundation for the Italian Primary Immune Deficiencies Centre. | |||
* 2009-2016: Coordinator of the Project: Role of antibiotic prophylaxis in patients with primary antibody deficiencies, founded by AIFA (Italian Agency of Drugs) Agenzia Italiana del Farmaco/AIFA. | |||
* 2020 up to now: Responsible of the project: IVIG in COVID-19 founded by AIFA (Italian Agency for drugs). | |||
* 2021-2022: Call for prevention, GSK. | |||
== External links == | == External links == | ||
Revision as of 11:33, 3 February 2023
Isabella Quinti is a Full Professor in Internal Medicine, Clinical Immunology, the School Director of Specialty in Allergy and Clinical Immunology and the Head of the Primary Immunodeficiency Unit at the Sapienza University of Rome, Italy.[1][2]
| Born |
| 1954 |
| Nationality |
| Italian |
| Education |
| Sapienza University of Rome, Italy |
| Fields |
| Immunology |
| Institutions |
| Sapienza University of Rome, Italy |
| Notes |
| Top Italian Scientist in Clinical Sciences [3] |
Work experience
- 1986-2002: Assistant Professor in Clinical Immunology, University of Rome “La Sapienza”, Italy.
- 2001-up to now: Head of the Primary Immunodeficiency Unit, Sapienza, University of Rome, Italy.
- 2010-up to now: Professor PhD School, INNOVATION IN IMMUNO-MEDIATED AND HEMATOLOGICAL DISORDERS, Sapienza, University of Rome, Italy.
- 2019-up to now: Director School of Specialty in Allergy and Clinical Immunology, Sapienza University of Rome, Sapienza, University of Rome, Italy.
- 2012-2020: Associate Professor in Internal Medicine, Clinical Immunology, Sapienza, University of Rome, Italy.
- 2021-up to now: Full Professor in Internal Medicine, Clinical Immunology, Sapienza, University of Rome, Italy.
Education and training
- 1972-1978: Medicine Degree, Sapienza University of Rome, Italy.
- 1978-1982: Specialist in Allergy and Clinical Immunology, Sapienza University of Rome, Italy.
- 1983-1984: Research fellow in Paediatrics, Children Hospital, Harvard University, Boston, Ma, USA.
- 1983-1985: Ph.D. in Clinical Immunology, University of Bari, Italy.
Scientific skills and competences
- Primary Immunodeficiencies: natural history, clinical outcome, immune therapies.
- Blymphocytes defects in primary immunodeficiencies syndromes.
- Response to Immunizations.
- B-cell lymphoproliferative disorders.
- Mucosal immunity.
Relevant roles and competences
- 2001 up to now: Responsible for Italian Network on CVID (IPINET: Italian Primary Immunodeficiency Network).
- 2008-2015: Responsible for the Sapienza Research Unit of the Medium-scale focused research Collaborative Research Project, founded by the European Commission:“Pathophysiology and Natural Course of Primary Antibody Deficiency (PAD) Syndromes (EURO-PADnet). 7° PQ EU.
- 2010-2022: Responsible of the Jeffrey Modell Foundation for the Italian Primary Immune Deficiencies Centre.
- 2009-2016: Coordinator of the Project: Role of antibiotic prophylaxis in patients with primary antibody deficiencies, founded by AIFA (Italian Agency of Drugs) Agenzia Italiana del Farmaco/AIFA.
- 2020 up to now: Responsible of the project: IVIG in COVID-19 founded by AIFA (Italian Agency for drugs).
- 2021-2022: Call for prevention, GSK.
External links
- Isabella Quinti - Google Scholar
- Isabella Quinti - Scopus
- Isabella Quinti - Head Primary Immune Deficiencies Unit - Sapienza University of Rome - Department of Molecular Medicine - Research profile
